Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Clement

Showing results (381-390 of 444) with videos related to

Pageof 45
Sort By:
Neuro-Oncology|May 25, 2019
Defining EGFR amplification status for clinical trial inclusionPim J French, Marica Eoli, Juan Manuel Sepulveda, et al.
Therapeutic Advances in Medical Oncology|October 27, 2023
Intra-individual qualitative and quantitative comparison of [<sup>68</sup>Ga]Ga-DOTATATE PET/CT and PET/MRIGéraldine Lens, Niloefar Ahmadi Bidakhvidi, Vincent Vandecaveye, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 20, 2022
<sup>18</sup>F-AlF-NOTA-Octreotide Outperforms <sup>68</sup>Ga-DOTATATE/NOC PET in Neuroendocrine Tumor Patients: Results from a Prospective, Multicenter StudyElin Pauwels, Frederik Cleeren, Térence Tshibangu, et al.
Cellular and Molecular Life Sciences : CMLS|April 24, 2020
Receptor-mediated endocytosis 8 (RME-8)/DNAJC13 is a novel positive modulator of autophagy and stabilizes cellular protein homeostasisAnna S Besemer, Joanna Maus, Mirjam D A Ax, et al.
Molecular Cell|June 12, 2020
Dysregulation of BRD4 Function Underlies the Functional Abnormalities of MeCP2 Mutant NeuronsYangfei Xiang, Yoshiaki Tanaka, Benjamin Patterson, et al.
Human Mutation|April 3, 2007
Epistatic interactions with a common hypomorphic RET allele in syndromic Hirschsprung diseaseL de Pontual, A Pelet, M Clement-Ziza, et al.
European Journal of Cancer (Oxford, England : 1990)|July 15, 2023
Health-related quality-of-life results from the randomised phase II TAVAREC trial on temozolomide with or without bevacizumab in 1p/19q intact first-recurrence World Health Organization grade 2 and 3 glioma (European Organization for Research and Treatment of Cancer 26091)Jaap C Reijneveld, Abigirl Machingura, Corneel Coens, et al.
Genes and Immunity|March 7, 2026
Immuno-molecular features and therapeutic implications of brain metastases in clear cell renal cell carcinoma patientsI Roodhooft, L Kinget, G Mammone, et al.
EJNMMI Research|June 1, 2023
Prospective comparison of [<sup>18</sup>F]AlF-NOTA-octreotide PET/MRI to [<sup>68</sup>Ga]Ga-DOTATATE PET/CT in neuroendocrine tumor patientsLennert Boeckxstaens, Elin Pauwels, Vincent Vandecaveye, et al.
JAMA|September 29, 2005
Comparison of the Canadian CT Head Rule and the New Orleans Criteria in patients with minor head injuryIan G Stiell, Catherine M Clement, Brian H Rowe, et al.
Pageof 45

Showing results (381-390 of 444) with videos related to

Sort By:
Pageof 45
Neuro-Oncology|May 25, 2019
Defining EGFR amplification status for clinical trial inclusionPim J French, Marica Eoli, Juan Manuel Sepulveda, et al.
Therapeutic Advances in Medical Oncology|October 27, 2023
Intra-individual qualitative and quantitative comparison of [<sup>68</sup>Ga]Ga-DOTATATE PET/CT and PET/MRIGéraldine Lens, Niloefar Ahmadi Bidakhvidi, Vincent Vandecaveye, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 20, 2022
<sup>18</sup>F-AlF-NOTA-Octreotide Outperforms <sup>68</sup>Ga-DOTATATE/NOC PET in Neuroendocrine Tumor Patients: Results from a Prospective, Multicenter StudyElin Pauwels, Frederik Cleeren, Térence Tshibangu, et al.
Cellular and Molecular Life Sciences : CMLS|April 24, 2020
Receptor-mediated endocytosis 8 (RME-8)/DNAJC13 is a novel positive modulator of autophagy and stabilizes cellular protein homeostasisAnna S Besemer, Joanna Maus, Mirjam D A Ax, et al.
Molecular Cell|June 12, 2020
Dysregulation of BRD4 Function Underlies the Functional Abnormalities of MeCP2 Mutant NeuronsYangfei Xiang, Yoshiaki Tanaka, Benjamin Patterson, et al.
Human Mutation|April 3, 2007
Epistatic interactions with a common hypomorphic RET allele in syndromic Hirschsprung diseaseL de Pontual, A Pelet, M Clement-Ziza, et al.
European Journal of Cancer (Oxford, England : 1990)|July 15, 2023
Health-related quality-of-life results from the randomised phase II TAVAREC trial on temozolomide with or without bevacizumab in 1p/19q intact first-recurrence World Health Organization grade 2 and 3 glioma (European Organization for Research and Treatment of Cancer 26091)Jaap C Reijneveld, Abigirl Machingura, Corneel Coens, et al.
Genes and Immunity|March 7, 2026
Immuno-molecular features and therapeutic implications of brain metastases in clear cell renal cell carcinoma patientsI Roodhooft, L Kinget, G Mammone, et al.
EJNMMI Research|June 1, 2023
Prospective comparison of [<sup>18</sup>F]AlF-NOTA-octreotide PET/MRI to [<sup>68</sup>Ga]Ga-DOTATATE PET/CT in neuroendocrine tumor patientsLennert Boeckxstaens, Elin Pauwels, Vincent Vandecaveye, et al.
JAMA|September 29, 2005
Comparison of the Canadian CT Head Rule and the New Orleans Criteria in patients with minor head injuryIan G Stiell, Catherine M Clement, Brian H Rowe, et al.
Pageof 45